Results 71 to 80 of about 1,375,308 (279)
Treatment options for polycystic ovary syndrome [PDF]
, 2011 Ahmed Badawy1 Abubaker Elnashar21Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt; 2Department of Obstetrics and Gynecology, Benha University, Benha, EgyptAbstract: Polycystic ovary syndrome (PCOS) is the most common ...
Ahmed Badawy +2 more
core +1 more source
Therapeutic JAK Inhibition in Idiopathic Subglottic Stenosis
The Laryngoscope, EarlyView.Three patients with idiopathic subglottic stenosis and rheumatoid arthritis began JAK inhibitor therapy, after which the mean surgical‐free interval between endoscopic dilations rose from 317 to 631 days and the annualized dilation rate fell from 1.24 to 0.38 per patient‐year. Figure 2 shows this as a per‐patient timeline.
Riley M. Larkin +5 more
wiley +1 more source
Albumin and Sex Hormone Binding Globulin based Testosterone Indices in Polycystic Ovarian Syndrome
Pakistan Armed Forces Medical JournalObjective: To evaluate total testosterone, “Free Androgen Index”, calculated free testosterone, % free testosterone, calculated bioavailable testosterone, and % testosterone as a possible biomarker to predict presence of Polycystic ovarian syndrome as ...
Sikandar Hayat Khan +5 more
doaj +1 more source
Combined oral contraceptives: the optimal range of examination. Part 1
Mìžnarodnij Endokrinologìčnij Žurnal, 2018 Combined oral contraceptives are effective drugs for contraception and treatment of reproductive disorders in polycystic ovarian syndrome. The article considers the main laboratory algorithms for excluding the most common endocrine diseases, the clinical
O.V. Rykova
doaj +1 more source
Beyond Joint Hypermobility: Investigating Bladder Dysfunction in Hypermobile Ehlers‐Danlos Syndrome
Neurourology and Urodynamics, EarlyView.ABSTRACT Introduction and Objectives Hypermobile Ehlers‐Danlos Syndrome (hEDS) is the most common subtype of Ehlers‐Danlos Syndrome, a group of connective tissue disorders caused by collagen abnormalities. While musculoskeletal features of hEDS are well characterized, its impact on visceral organs, including the bladder, remains underexplored.
Marium Ansari +5 more
wiley +1 more source
, 2017 Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women. It is related to ovarian androgen excess and manifests as hirsutism, irregular menstrual cycles, and ovarian cysts seen on an ultrasonogram. Two out of three features are required to make a diagnosis. Obesity is often associated with PCOS. Symptoms are usually seen from puberty.
Ana Luisa Alencar De Nicola +1 more
+4 more sources
Application of Herbal Medicines for Obesity Treatment in the Polycystic Ovarian Syndrome Women
, 2020 Polycystic ovarian syndrome (PCOS) is a frequent disorder commonly found in reproductive-aged women. The disease PCOS in women is considered to be complex heterogeneity, which indicates the combined combination of genetics and environmental interaction
Sameera A. Alghamdi
core +1 more source
Obesity, EarlyView.ABSTRACT Objective SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through ...
Martin K. Rutter +14 more
wiley +1 more source
Reproductive Biology and Endocrinology, 2018 Background The injection of estradiol valerate in female rats induces polycystic ovary syndrome, which is characterized by polycystic ovaries, anovulation, and hyperandrogenism.
Julieta A. Espinoza +4 more
doaj +1 more source
Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome [PDF]
, 2018 Introduction: Hyperandrogenism remains as one of the key features in Polycystic Ovarian Syndrome (PCOS) and can be assessed clinically or determined by biochemical assays. Hirsutism is the most common clinical manifestation of hyperandrogenism.
Razali, Nuguelis +2 more
core